The title compound, C7H7N3O2S, was prepared for comparison with diazox
ide, an antihypertensive agent, from a structural and pharmacological
point of view. The crystal structure determination shows that the (rat
her than 2H) tautomeric form is preferentially adopted by this pyridot
hiadiazine derivative in the solid state.